A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(83 sites)

United States

Allervie Clinical Research, Birmingham, Alabama

Kern Allergy Medical Clinic, Inc, Bakersfield, California

Integrated Research of Inland, Inc, Upland, California

Qway Research, Hialeah, Florida

Direct Helpers Research Center, Hialeah, Florida